U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07852000) titled 'Radiomics for Distinguishing Benign and Malignant Lung Nodules' on Sept. 25.
Brief Summary: Differentiating between benign (non-cancerous) and malignant (cancerous) pulmonary nodules is a critical step in determining appropriate patient management and cancer treatment planning. Conventional evaluation using chest computed tomography (CT) relies on visual inspection of features such as size, shape, and borders; however, benign and malignant nodules frequently exhibit overlapping characteristics, which often necessitates invasive biopsy procedures.
Radiomics is an emerging analytical technique that extracts high-dimensional quantitati...